Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart.

Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart.

by

Heart failure stays a significant well being burden around the globe. Despite nice progress in delineation of molecular mechanisms underlying growth of illness, normal remedy has not superior on the similar tempo.

The multifunctional signaling molecule Ca2+/calmodulin-dependent protein kinase II (CaMKII) has acquired appreciable consideration over current years for its central function in maladaptive reworking and arrhythmias in the setting of power illness.

However, these primary science discoveries have but to translate into new therapies for human sufferers. This overview addresses each the promise and boundaries to growing translational therapies that focus on CaMKII signaling to abrogate pathologic reworking in the setting of power illness.

Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart.
Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart.

Efforts in small molecule design are mentioned, in addition to various focusing on approaches that exploit novel avenues for compound supply and/or genetic approaches to have an effect on cardiac CaMKII signaling. These various methods present hope for overcoming some of the challenges which have restricted the event of new therapies.

Carboxy-DCFDA
GW5389-1 1
EUR 999.9

Carboxy-DCFDA
GW5389-100 100
EUR 207.1

Carboxy-DCFDA N-succinimidyl ester
GW9790 50mg
EUR 1495.83

Carboxy-DCFDA N-succinimidyl ester
GW9790-250 250
EUR 1427.9

Carboxy-DCFDA N-succinimidyl ester
GW9790-50 50
EUR 379.2

Human complement factor D-CFD-ELISA Kit
QY-E04079 96T
EUR 450

CD7(124.1D1), CF568 conjugate, 0.1mg/mL
BNC681046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF568 conjugate, 0.1mg/mL
BNC681046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF594 conjugate, 0.1mg/mL
BNC941046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF594 conjugate, 0.1mg/mL
BNC941046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF647 conjugate, 0.1mg/mL
BNC471046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF647 conjugate, 0.1mg/mL
BNC471046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF488A conjugate, 0.1mg/mL
BNC881046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF488A conjugate, 0.1mg/mL
BNC881046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF640R conjugate, 0.1mg/mL
BNC401046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF640R conjugate, 0.1mg/mL
BNC401046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF405S conjugate, 0.1mg/mL
BNC041046-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD7(124.1D1), CF405S conjugate, 0.1mg/mL
BNC041046-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Rabbit Anti Human IGHG4 Monoclonal Clone DCF-9
IRBAHUIGHG4DCF9C100UL each
EUR 496
Description: Rabbit Anti Human IGHG4 Monoclonal Clone DCF-9

DCFBC
MBS5775025-5mg 5(mg
EUR 915

DCFBC
MBS5775025-5x5mg 5x5(mg
EUR 3970

DCFBC
T25293-10mg 10mg Ask for price
Description: DCFBC

DCFBC
T25293-1g 1g Ask for price
Description: DCFBC

DCFBC
T25293-1mg 1mg Ask for price
Description: DCFBC

DCFBC
T25293-50mg 50mg Ask for price
Description: DCFBC

DCFBC
T25293-5mg 5mg Ask for price
Description: DCFBC

DCFBC F-18
MBS5775026-5mg 5(mg
EUR 915

DCFBC F-18
MBS5775026-5x5mg 5x5(mg
EUR 3970

DCFPYL
MBS5780845-5mg 5(mg
EUR 915

DCFPYL
MBS5780845-5x5mg 5x5(mg
EUR 3970

DCFPYL
T31224-10mg 10mg Ask for price
Description: DCFPYL

DCFPYL
T31224-1g 1g Ask for price
Description: DCFPYL

DCFPYL
T31224-1mg 1mg Ask for price
Description: DCFPYL

DCFPYL
T31224-50mg 50mg Ask for price
Description: DCFPYL

DCFPYL
T31224-5mg 5mg Ask for price
Description: DCFPYL

DCFBC F-18
T25294-10mg 10mg Ask for price
Description: DCFBC F-18

DCFBC F-18
T25294-1g 1g Ask for price
Description: DCFBC F-18

DCFBC F-18
T25294-1mg 1mg Ask for price
Description: DCFBC F-18

DCFBC F-18
T25294-50mg 50mg Ask for price
Description: DCFBC F-18

DCFBC F-18
T25294-5mg 5mg Ask for price
Description: DCFBC F-18

Dcfpyl F-18
MBS5775027-5mg 5(mg
EUR 915

Dcfpyl F-18
MBS5775027-5x5mg 5x5(mg
EUR 3970

Dcfpyl F-18
T25295-10mg 10mg Ask for price
Description: Dcfpyl F-18

Dcfpyl F-18
T25295-1g 1g Ask for price
Description: Dcfpyl F-18

Dcfpyl F-18
T25295-1mg 1mg Ask for price
Description: Dcfpyl F-18

Dcfpyl F-18
T25295-50mg 50mg Ask for price
Description: Dcfpyl F-18

Dcfpyl F-18
T25295-5mg 5mg Ask for price
Description: Dcfpyl F-18

Bax(2D2), CF568 conjugate, 0.1mg/mL
BNC680004-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF568 conjugate, 0.1mg/mL
BNC680004-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF594 conjugate, 0.1mg/mL
BNC940004-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF594 conjugate, 0.1mg/mL
BNC940004-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF647 conjugate, 0.1mg/mL
BNC470004-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF647 conjugate, 0.1mg/mL
BNC470004-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF488A conjugate, 0.1mg/mL
BNC880004-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF488A conjugate, 0.1mg/mL
BNC880004-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF640R conjugate, 0.1mg/mL
BNC400004-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF640R conjugate, 0.1mg/mL
BNC400004-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF405S conjugate, 0.1mg/mL
BNC040004-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Bax(2D2), CF405S conjugate, 0.1mg/mL
BNC040004-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF568 conjugate, 0.1mg/mL
BNC680424-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF568 conjugate, 0.1mg/mL
BNC680424-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF568 conjugate, 0.1mg/mL
BNC680985-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF568 conjugate, 0.1mg/mL
BNC680985-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF568 conjugate, 0.1mg/mL
BNC681049-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF568 conjugate, 0.1mg/mL
BNC681049-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF594 conjugate, 0.1mg/mL
BNC940424-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF594 conjugate, 0.1mg/mL
BNC940424-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF594 conjugate, 0.1mg/mL
BNC940985-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF594 conjugate, 0.1mg/mL
BNC940985-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF594 conjugate, 0.1mg/mL
BNC941049-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF594 conjugate, 0.1mg/mL
BNC941049-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF647 conjugate, 0.1mg/mL
BNC470424-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF647 conjugate, 0.1mg/mL
BNC470424-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF647 conjugate, 0.1mg/mL
BNC470985-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF647 conjugate, 0.1mg/mL
BNC470985-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF647 conjugate, 0.1mg/mL
BNC471049-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF647 conjugate, 0.1mg/mL
BNC471049-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF488A conjugate, 0.1mg/mL
BNC880424-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF488A conjugate, 0.1mg/mL
BNC880424-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF488A conjugate, 0.1mg/mL
BNC880985-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF488A conjugate, 0.1mg/mL
BNC880985-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF488A conjugate, 0.1mg/mL
BNC881049-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF488A conjugate, 0.1mg/mL
BNC881049-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF640R conjugate, 0.1mg/mL
BNC400424-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF640R conjugate, 0.1mg/mL
BNC400424-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF640R conjugate, 0.1mg/mL
BNC400985-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF640R conjugate, 0.1mg/mL
BNC400985-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF640R conjugate, 0.1mg/mL
BNC401049-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF640R conjugate, 0.1mg/mL
BNC401049-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF405S conjugate, 0.1mg/mL
BNC040424-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD147(8D6), CF405S conjugate, 0.1mg/mL
BNC040424-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF405S conjugate, 0.1mg/mL
BNC040985-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(152-1D5), CF405S conjugate, 0.1mg/mL
BNC040985-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF405S conjugate, 0.1mg/mL
BNC041049-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD84(153-4D9), CF405S conjugate, 0.1mg/mL
BNC041049-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF568 conjugate, 0.1mg/mL
BNC680028-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF568 conjugate, 0.1mg/mL
BNC680028-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

S100A9(47-8D3), CF568 conjugate, 0.1mg/mL
BNC681093-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

S100A9(47-8D3), CF568 conjugate, 0.1mg/mL
BNC681093-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF594 conjugate, 0.1mg/mL
BNC940028-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF594 conjugate, 0.1mg/mL
BNC940028-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

S100A9(47-8D3), CF594 conjugate, 0.1mg/mL
BNC941093-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

S100A9(47-8D3), CF594 conjugate, 0.1mg/mL
BNC941093-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF555 conjugate, 0.1mg/mL
BNC550028-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF555 conjugate, 0.1mg/mL
BNC550028-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF647 conjugate, 0.1mg/mL
BNC470028-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD45RA(158-4D3), CF647 conjugate, 0.1mg/mL
BNC470028-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

S100A9(47-8D3), CF647 conjugate, 0.1mg/mL
BNC471093-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

S100A9(47-8D3), CF647 conjugate, 0.1mg/mL
BNC471093-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TGF-beta(1D11.16.8), CF770 conjugate, 0.1mg/mL
BNC700977-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TGF-beta(1D11.16.8), CF770 conjugate, 0.1mg/mL
BNC700977-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD195 / CCR-5(12D1), CF568 conjugate, 0.1mg/mL
BNC680156-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD195 / CCR-5(12D1), CF568 conjugate, 0.1mg/mL
BNC680156-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD50 (ICAM-3)(101-1D2), CF568 conjugate, 0.1mg/mL
BNC680177-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD50 (ICAM-3)(101-1D2), CF568 conjugate, 0.1mg/mL
BNC680177-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TGF-beta(1D11.16.8), CF568 conjugate, 0.1mg/mL
BNC680977-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

TGF-beta(1D11.16.8), CF568 conjugate, 0.1mg/mL
BNC680977-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD195 / CCR-5(12D1), CF594 conjugate, 0.1mg/mL
BNC940156-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD195 / CCR-5(12D1), CF594 conjugate, 0.1mg/mL
BNC940156-500 500uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

CD50 (ICAM-3)(101-1D2), CF594 conjugate, 0.1mg/mL
BNC940177-100 100uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Leave a Comment